ARCHIVES

Waksal To Pay Back $800,000 In Profits From Stock Sales

This article is from The Cancer Letter archive.

Vol. 29 No. 11 | March 14, 2003

Download PDF Visit The Full Archive

Related Articles

NMP22 Assay More Effective Than Conventional Lab Test

January 27, 2006

Two-Year Remission While Taking Gleevec Puts Patients Into Normal Mortality Rate

March 25, 2011

DeVita: No Decision Yet On FCRF Award

July 17, 1987

PRI Drops Suit Against Top Two FCRF Staff; Gilden, Compton Accept “Partnership” Offers

August 22, 1986

FDA Nearly Wrecks NCI Drug Distribution Program, Finally Agrees To New Guidelines

January 30, 1976

Burzynski, Monaco Clashed In Court

June 5, 1992